A confirmatory study on the effect of continuous intake of test food on bone metabolism. -A placebo-controlled, randomized, double-blind clinical trial

Not Applicable

• Conditions: Healthy adults

• Registration Number: JPRN-UMIN000046979
• Lead Sponsor: IMEQRD Co., Ltd

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2022-02-27
• Study Completion: 2022-09-30
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Complete: follow-up continuing
• Sex: Female
• Target Recruitment: 40

Inclusion Criteria

Not provided

Exclusion Criteria

1.Currently undergoing treatment for any disease, or receive medical treatment such as medical drugs or traditional Chinese medicines. Medications used as needed are acceptable. 2.Receiving nutritional and exercise therapy by medical doctors. 3.Have severe diseases or a history of severe diseases. 4.Received hormone replacement therapy within six months before the study. 5.Have experienced bone-related diseases such as bone fracture within six months before the study. 6.Have artificial materials or foreign substances in the bones with surgeries or any reason. 7.Have the Young Adult Mean% less than 70%. 8.Received barium swallow test within 7 days before the day of visit. 9.Have currently been taking commercially available drugs, quasi-drug products, foods, or supplements with any functional claims. However, can discontinue taking these drugs/foods during the trial period is acceptable to join the study. 10.Have allergies to drugs or foods. 11.Planning extremely change lifestyle (such as diet, sleep, or exercise) during the study period. 12.Planning travel to foreign countries during the study period. 13.Taking more than 60 g alcohol/day. 14.Smoking within one year before the trial. 15.Individuals who joined other clinical trials from one month before the trial, individuals who have currently been joined other clinical trials, and also Individuals who are planning to join other clinical trials during the trial. 16.Unsuitable for the study, that judged by the principal investigator.

Study & Design

• Study Type: Interventional
• Study Design: Not specified